KRX Aesthetics PD-13 Therapy

Manufacturer
KRX RESOURCES SDN. BHD.
Effective date
2026-04-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:52:18

Label at a glance#

ProductKRX Aesthetics PD-13 Therapy
Active ingredientMETHYL AMINOLEVULINATE HYDROCHLORIDE
Label structure8 sections

Label contents#

Full prescribing information#

DOSAGE & ADMINISTRATION SECTION

How to use Krx Aesthetics PD-13 Therapy

1. Cleanse and exfoliate the skin. 2. Extraction of blackheads and whiteheads if necessary. 3. Apply Krx Aesthetics PDT 13% treatment and cover the skin. 4. Make sure the skin is fully covered / not exposed to light for 30 minutes. 5. Remove excess product on skin by wiping with sponge. 6. Use RED LED light for 20 minutes. Cover eyes. 7. Neutralize with Krx Aesthetics P DT Neutralizer. 8. Apply mask and repair cream. 9. Use sunblock.

WARNINGS SECTION

1. Keep out of reach of children 2. If irritation occurs, consult your dermatologist and stop usage. Please, check how to use the product and the precautions before you use it.

INACTIVE INGREDIENT SECTION

Glycerin, Propylene Glycol, Methyl Ami nolevulinate HCl, 1, 2- Hexanediol, Alcohol, Sodium Lactate, Water, Pentylene Glycol, Dipropylene Glycol

INDICATIONS & USAGE SECTION

Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

OTC - PURPOSE SECTION

Krx Aesthetics PD-13 Therapy, which includes 13% of Methyl Aminolevulinate HCI, is developed to maximize the client’s satisfaction for PDT(Photo Dynamic Therapy).

OTC - ACTIVE INGREDIENT SECTION

Methyl Aminolevulinate HCI 13%

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Complete LabelingComplete LabelingPackage Labeling

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
METHYL AMINOLEVULINATE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84755-0010-1KRX Aesthetics PD-13 Therapy15 mL in 1 PACKAGESPRAY151

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84755-001084755-0010-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KRX Aesthetics PD-13 TherapyKRX AESTHETICS PD-13 THERAPYKRX RESOURCES SDN. BHD.4e6af886-2e2e-0343-e063-6394a90ad0952026-04-01WarningsExact identifier
ndc (package): 84755-0010-1
ndc (product): 84755-0010
ndc11 (package): 84755001001
spl id: 4e6af886-2e2f-0343-e063-6394a90ad095
spl set id: 4e6af886-2e2e-0343-e063-6394a90ad095

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.